(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ÁCIDOS NUCLEICOS LIGANDO-2'-MODIFICADOS, SÍNTESE DOS MESMOS, E INTERMEDIÁRIOS PARA OS MESMOS

ArquivadaInvention PatentPCT · US2020048313

Application data

Number

112022003861

Type

Invention Patent

Filing

08/28/2020

Publication

05/24/2022

PCT

US2020048313

Progress at the INPI

  1. Filing08/28/20
  2. Publication05/24/22
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 08/28/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 12/05/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

DICERNA PHARMACEUTICALS, INC.

US

See this company's full portfolio

Inventors

N. N. (pessoa física)

US

W. W. (pessoa física)

US

Technical data

Priority claims

US

62/894,071 · 08/30/2019

Abstract

ÁCIDOS NUCLEICOS LIGANDO-2'-MODIFICADOS, SÍNTESE DOS MESMOS, E COMPOSTOS INTERMEDIÁRIOS PARA OS MESMOS.A presente invenção refere-se a métodos para sintetizar compostos úteis como agentes de interferência de RNA potentes e estáveis, derivados dos mesmos e intermediários dos mesmos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

12/05/2023

RPI 2761

Arquivamento - Art. 33 da LPI

#11.1

09/19/2023

RPI 2750

Notificação de entrada na fase nacional - PCT

#1.3

05/24/2022

RPI 2681

Alteração de dados cadastrais

#1.1

03/15/2022

RPI 2671

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.